HRT Financial’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-176,688
| Closed | -$4.39M | – | 3005 |
|
|
2025
Q1 | $4.39M | Sell |
176,688
-3,213
| -2% | -$79.8K | 0.03% | 400 |
|
|
2024
Q4 | $3.39M | Buy |
+179,901
| New | +$3.39M | 0.02% | 452 |
|
|
2023
Q2 | – | Sell |
-6,645
| Closed | -$271K | – | 2847 |
|
|
2023
Q1 | $271K | Sell |
6,645
-153,077
| -96% | -$6.24M | ﹤0.01% | 1623 |
|
|
2022
Q4 | $6.17M | Buy |
159,722
+137,685
| +625% | +$5.32M | 0.09% | 203 |
|
|
2022
Q3 | $1.17M | Buy |
+22,037
| New | +$1.17M | 0.01% | 787 |
|
|
2021
Q4 | – | Sell |
-19,157
| Closed | -$1.07M | – | 3535 |
|
|
2021
Q3 | $1.07M | Sell |
19,157
-35,147
| -65% | -$1.97M | 0.01% | 1075 |
|
|
2021
Q2 | $3.3M | Buy |
+54,304
| New | +$3.3M | 0.03% | 398 |
|
|
2019
Q4 | – | Sell |
-7,938
| Closed | -$302K | – | 1440 |
|
|
2019
Q3 | $302K | Buy |
+7,938
| New | +$302K | 0.01% | 836 |
|
|
2019
Q1 | – | Sell |
-7,866
| Closed | -$338K | – | 686 |
|
|
2018
Q4 | $338K | Buy |
+7,866
| New | +$338K | 0.05% | 302 |
|